We conducted a cross-sectional survey of 1322 parents of children with asthma to measure the prevalence and factors associated with complementary and alternative medicine (CAM) use for pediatric asthma. Multivariate regression techniques were used to determine factors associated with CAM use. Eleven percent (141/1322) of children were given CAM. Parents of children on daily medications who were perceived to have poor asthma control were almost three times more likely to use CAM than parents of children on no daily medications who were perceived to have high asthma control (risk ratio: = 2.81; confi dence interval: 1.72, 4.60); age, gender, race, income, and education level were not signifi cant independent predictors. Parent perception of asthma control is signifi cantly associated with CAM use. It is important for providers to elicit information regarding CAM use in the clinic, as this may imply that the asthma symptoms may not be well controlled.
Introduction
T he use of complementary and alternative medicine (CAM), defi ned as practices, products and health-care systems that are not usually included or delivered in traditional medical systems, 1 has become more prevalent for children. 2 Studies have noted higher CAM use for children with asthma or respiratory symptoms. 3, 4 Furthermore, several cross-sectional studies of CAM use for children with asthma in multicultural communities [5] [6] [7] have reported a prevalence of CAM use as high as 89%.
Given the prevalence of asthma and the increasing use of CAM, it is not unusual for primary care clinicians to deal with both issues. A key step in management is identifying CAM attitudes and practices and discussing how such therapies may affect conventional asthma medicines. In some cases CAM interventions for asthma and allergic disease have been associated with increased hospitalizations, 8 adverse events, 9 or potentially dangerous interactions of CAM therapies such as ephedra with albuterol causing cardiovascular effects. 10 Use of CAM may also potentially affect adherence to conventional medical therapies. 11 Despite the importance of these issues, communication about CAM use is not ideal, as few health-care providers are aware of parent CAM use for their children. 1, 3, 6 Furthermore, although motivations for adult patients to use CAM have been explored, there is relatively little understanding of the factors associated with and potential motivation for CAM use in children.
In this study, we interviewed a cross-section of parents of children with asthma to examine CAM use for pediatric asthma. Unlike previous studies, the families involved in this study represent a variety of practice settings (rural, urban, and suburban). The purpose of this study was to measure the prevalence of CAM use and the factors associated with CAM use for pediatric asthma.
Materials and Methods
We analyzed baseline data from a randomized clinical trial designed to evaluate the effect of physician asthma education on provider adherence to National Heart Lung and Blood Institute (NHLBI) guidelines for the management of asthma in children. The institutional review boards of the University of Michigan and the University of California, San Francisco approved the study protocol. Analyses from this dataset have been used to examine parent attitudes regarding asthma management, as well as to validate a "Beliefs in Medications" questionnaire.
Patient population
We developed a registry of patients with asthma from the patient panels of pediatricians involved in the study. Project staff successfully contacted the adult-usually responsible for the child's health-related care and who takes him/her to the doctor-of 3263 patients by telephone to invite further study participation, answer questions, obtain informed consent, and screen for eligibility. Of the 3263 patients whose parents could be contacted, 1858 met eligibility criteria.
Eligibility criteria included being the patient of a study physician, having a diagnosis of asthma and having utilized health-care services in the preceding 2 years, being between 2 and 12 years of age, and having no other diseases associated with pulmonary complications, such as tuberculosis, sickle cell disease, or cystic fi brosis. We included only one child per family. We excluded children if they had a parent who worked for a study physician or if children were under 2 years of age, given that the diagnosis of asthma can be diffi cult to establish before age 2.
Parents 
Data collection
Trained interviewers administered the baseline survey to parents by telephone. The telephone interview averaged 20 min in duration and was conducted in English for the majority of parents. It was also conducted in Spanish, Arabic, and Bengali in the relatively few instances when it was necessary. As part of this survey, parents were asked to provide demographic information including patient age, race, gender, and insurance type; the total annual combined household income in categories of ~$10,000 increments; the number of persons dependent on this income; and the highest level of school completed. To determine asthma severity, parents were asked about symptom frequency: (1) "In the past month, how many nights have symptoms such as coughing, wheezing, chest tightness, or shortness of breath interfered with (child's) sleep?" and (2) "In the past month, how many days have symptoms such as coughing, wheezing, chest tightness, or shortness of breath interfered with running, playing games or sports?" 14 To determine the parents' perception of their child's current asthma control, we asked parents to rate, "how controlled has your child's asthma been over the last month (28 days)" using a scale from 1 to 5, where 1 was "not controlled at all" and 5 was "very controlled."
Parents were asked to list each asthma medication currently prescribed by a physician. To gather data on the prevalence of use of complementary and alternative medicine, parents were also asked the following question: "In the past 12 months, have you used alternative home remedies, including herbs, teas, dietary changes, breathing exercises, meditation, prayer, massage, biofeedback, or homeopathy to control [your child]'s asthma symptoms?"
Classifi cation of CAM therapies
To classify parent responses into CAM categories, two investigators examined the verbatim responses of each of the parents who indicated use of alternative medicine using the National Institutes of Health National Center for Complementary and Alternative Medicine classifi cation system (Table 1) . These categories included alternative medical systems, mind-body interventions, biologically based therapies, manipulative and body-based methods, and energy therapies. In a handful of cases, parents described two CAM therapies as a single therapy. In these cases, the therapy was classifi ed in relation to the initial therapy described. Responses that were consistent with conventional therapies for asthma (e.g., use of air fi lters, allergen avoidance, exercise, etc.) were excluded from further classifi cation (Table 2) . Although breathing exercises are used for vocal cord dysfunction associated with asthma, none of the patients in our sample reported this condition.
Variables
Our dependent variable was the use of CAM for asthma. Independent variables included patient characteristics (age, gender, and severity of asthma), parent perception of the child's asthma control, current asthma management (name and type of daily medication used), and caregiver characteristics (age, ethnicity, race, location of birth, income, education level, and insurance status).
We dichotomized the level of caregiver education by collapsing responses into one of two categories, "college graduate" versus "noncollege graduate." The variable for race was collapsed into white and nonwhite. We used the defi nition of poverty published by the United States Department of Health and Human Services in 2004 to determine whether 15 We created the following six categories: income less than the Federal Poverty Line (FPL), income greater or equal to the FPL and less than two times the FPL, income greater or equal to twice the FPL and less than three times the FPL, etc. until a category of income greater than fi ve times the FPL.
We categorized each patient based on the use of a daily controller medication versus no daily controller medication. Controller medications included daily inhaled corticosteroids, leukotriene modifi ers, long-acting β-agonists, and combination medications.
Based on inspection of the data, we dichotomized the level of caregiver perception of their child's asthma into one of two categories, "not controlled," if they rated the child's asthma control as 1-3; versus "controlled," if they rated the child's asthma control as 4 or 5.
Analysis
Categorical variables were compared using the χ 2 statistic or, where expected cell counts were less than fi ve, Fisher's exact test Table 3 . Means of continuous variables (child age, caregiver age) were compared using Student's t-test. Multivariate logistic regression was performed with use of CAM as the dependent variable, controlling for the following independent variables: child gender, use of a daily controller medicine, caregiver perception of asthma control, and caregiver age, race, place of birth, income relative to the poverty line, education, and insurance coverage.
We used a generalized estimating equation (GEE) to control for correlated or clustered responses among patients of the same physician. All statistical analyses were performed using SAS Version 9.1 software (SAS Institute, Cary, NC). Statistical signifi cance was defi ned as p < 0.05.
Results
Characteristics of the 1322 children, their caregivers, and their households are presented in Table 3 .
Frequency and perceived effects of CAM use
Of the 1322 children, 141 (10.7%) had been given CAM for their asthma in the last year. The 141 caregivers described 187 different examples of CAM, for an average of 1.3 instances of CAM use for asthma per family. Table 1 provides categories of CAM use, the frequency with which each was cited, and examples. There were an additional 247 examples of therapies, initially described by parents as CAM (Table 2 ). However, these therapies did not fall into CAM defi nitions and were excluded from further analysis.
For the 187 examples of CAM use, in over two-thirds of the cases (68%), the therapy was self-recommended (Table 4) . For 13% of cases of CAM use, caregivers stated that a medical practitioner, not necessarily the child's physician, had made the CAM recommendation. The high frequency of selfreferral for CAM was consistent by type of CAM category.
When asked about the effects of CAM use, in 88% of instances of CAM use, caregivers reported a positive effect. Although in one-third of cases (68 of 187 cases) the positive effect was unspecifi ed, in many cases caregivers reported changes in relief of asthma or respiratory symptoms, a "calming effect" or a perception that the CAM use prevented future asthma exacerbations or symptoms.
Factors associated with CAM use
We explored an interaction between parent's perception of the child's asthma control and the use of a daily controller medication, as the likelihood of CAM use might be associated with the presence of poor asthma control, despite the use of a daily controller medication. In the adjusted model, using GEE to control for correlated responses among patients of the same physician, the single independent predictor of CAM use was the use of a daily medication with perceived poor asthma control [odds ratio (OR): 2.81; 95% confi dence interval (CI): 1.72, 4.60]. No other demographic characteristics were associated with CAM use for asthma (Table 5) .
We repeated our analysis with the use of biologicallybased CAM (e.g., herbs, teas, and supplements) for asthma as the dependent variable. This type of CAM use may be more likely to be implicated for interactions with conventional asthma therapies. In this model, increasing age of the patient (OR: 1.11; 95% CI: 1.05, 1.17) , in addition to the use of a daily asthma controller with perception of poor asthma control (OR: 2.26; 95% CI: 1.09, 4.68), was associated with increased likelihood of CAM use. No other variables were signifi cant.
Discussion
In our sample, one in nine parents with a child with asthma reported CAM use within the last year. In addition, no demographic factors were associated with CAM use for et al. reported a higher prevalence of CAM use for asthma compared to our analysis (65% versus 11%, respectively) in a population from a similar but smaller cross-section of settings, 18 our analyses excluded over-the-counter medications as a type of biologically based CAM.
In multivariate analysis, we found that no demographic factors are associated with parental report of CAM use for their child. One reason may be the broad defi nition of CAM, which ranges from mind-body interactions (e.g., prayer, etc.) to biologically based interventions (e.g., herbs, etc). We repeated the analyses with CAM use limited to only biologically based interventions and found no overall difference in our results.
Another factor that may explain why CAM use is also independent of demographic characteristics was the fact that we controlled for parent perception of asthma control. Parental perception of asthma control is independent of any demographic characteristic, and is a refl ection of the underlying asthma severity and the perceived success of current management. 19 Furthermore, there was effect modifi cation of the perception of asthma control through an interaction with the child's current use of daily asthma medications. If parents perceive that their child's asthma control is poor and the child was already taking a daily asthma medication, the likelihood of CAM use for asthma was signifi cantly increased, more than each single factor alone. This fi nding is similar to patterns observed for older patients, as adults with self-reported poorer health status were more likely to use CAM. 20 asthma. As a result, health-care providers should not make assumptions about which families use CAM, but instead evaluate potential CAM use in all families. We also found that one factor that is associated with CAM use is the parent perception of control of asthma symptoms. If parents' perceive that their child's asthma control is poor and the child is already taking a daily asthma medication, the likelihood of CAM use for asthma is signifi cantly increased.
Our estimates of CAM use for asthma are less than other reported studies. [5] [6] [7] However, although these studies also focused on children with asthma, the samples were drawn from single, multicultural communities within large cities. Our estimate of CAM use for asthma is consistent with other broader, representative samples. 16, 17 Our sample was drawn from three counties in Southeastern Michigan, which offer a cross-section of different practice settings (rural, suburban, urban, and small cities). Although Sidora-Arcoleo These fi ndings have implications for clinical care. The NHLBI guidelines recommend that physicians develop a partnership with families and attempt to screen for parent concerns about asthma. 15 For example, health-care providers can ask, "how well controlled do you think your child's asthma is?" If the level of asthma control is a concern, healthcare providers can initiate further management and develop a concrete plan to specifi cally address this issue. Studies suggest that use of simple, direct communication techniques to address parent questions and improve adherence do not necessarily require additional clinician time during the visit. 21 If parent concerns are not addressed, there is a lower likelihood of adherence. 22 This study would also suggest that such parents may be more likely to try CAM therapies for their child's asthma. In two-thirds of cases, CAM use for asthma was initiated by the parents themselves.
Limitations
Despite the cross-section of practice settings in our sample, our data were only from Southeastern Michigan, which may not be generalizable. We did not collect information about previous parental CAM self-use, which has been shown to be associated with parental use of CAM for their children. Although this variable is not in our analyses, it is unlikely to affect key variables in the analyses, such as parent perception of asthma severity or physician prescription of a daily asthma controller medication.
Finally, according to the NHLBI guidelines, asthma control is based on objective pulmonary function tests, as well as parent description of symptom frequency.
14 In addition, with there are other questionnaires to systematically assess asthma control, 19 we did not collect lung function data or utilize other questionnaire methods. As a result, we were unable to correlate patient perception of control with 
Conclusions
This study offers additional insight into potential motivation for parent use of CAM for their children, as parent's perception of asthma control is signifi cantly associated with CAM use. In developing a rapport with parents, it is important to elicit parent concerns and address perceptions of asthma control. No demographic factors were associated with general CAM use. As a result, health-care providers should not make assumptions and should screen and assess all families about potential CAM use, as well as be prepared to address how CAM use may affect current asthma management.
